Detail akcie Icecure Medical Rg online

Business Summary: Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Icecure Medical Ltd revenues decreased 13% to $2.1M. Net loss remained flat at $10.8M. Revenues reflect Other segment decrease of 39% to $393K, Japan segment decrease of 71% to $98K. Net income reflects Sales and marketing expenses decrease of 24% to $3.1M (expense), Research and development expenses decrease of 5% to $5.1M (expense).